Secukinumab acts by inhibiting the function of specific molecules in the body that cause psoriasis symptoms.
secukinumab
This medicine is used in treating plaque psoriasis (inflammatory skin disorder), psoriatic arthritis (patients with psoriasis who experience arthritis symptoms), and ankylosing spondylitis (arthritis that affects the spine).
Contradications
This medicine is not indicated for patients who have an allergy to Secukinumab or any of the other inactive components present in it.
Side effects
Some patients may experience increased infections, diarrhea, or oral herpes (infection of mouth due to herpes virus). Please consult your doctor if you experience any of these symptoms.
Expert Advice
Secukinumab should be kept in the fridge in its original packaging. This keeps the medicine cool and shields it from light. Once you're ready to administer the injection, remove the pen or syringe from the fridge and allow it to come to room temperature. This normally takes 15 to 30 minutes, however, do not leave it out for over an hour at room temperature. Always ensure that the medicine is transparent, colorless, or faintly yellow, and free of particles. Do not use secukimab injection that is discolored, cloudy, or contains particles. Keep Secukimab out of children’s and pets’ reach.
FAQs
What is the action of Secukinumab?
How long does Secukinumab take to work?
This varies according to your dosage and symptoms. It may probably take a number of weeks for you to notice the benefits of Secukinumab.
Is Secukinumab toxic to the immune system?
Yes, Secukinumab may reduce your immune response and avoid inflammation. This is why taking Secukinumab increases your chance of infection.
What should be done if a dose is missed?
Because Secukinumab is provided by a skilled healthcare practitioner in a hospital or clinical settings, there is very little chance of a missed dose. If you miss a scheduled dosage of Secukinumab, consult your doctor right away for further advice.
Is Secukinumab a medicine that can lead to addiction?
There were no reports of habit-forming characteristics in Secukinumab.
Medicines containing secukinumab
Rs.59467
